Physician

James W Neel, MD

According to 2025 Medicare claims, James Neel, MD (NPI: 1447232772) practices hematology/oncology in the Palm Bay-Melbourne-Titusville, FL market, with the plurality of this provider's patient population coming from Brevard, FL. This provider's primary affiliated billing organization is HEALTH FIRST MEDICAL GROUP, LLC (NPI: 1750626495; TIN: 461243081) and primary practice location at 32901-1973. Neel is affiliated with the Privia Quality Network Central Florida, LLC (ACO ID: A4947), participating under the MSSP model.

Neel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 983 traditional Medicare patients, billed 201,651 HCPCS/CPT codes, and received $3,089,009 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,374 prescription claims across 206 beneficiaries totaling $4,579,879 in drug costs, led by Ibrance (Palbociclib). DME data shows 86 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $974,039 to $4,579,879. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	912	91,463	$1,834,277
2016	952	113,244	$1,942,153
2017	1,011	147,839	$2,399,991
2018	1,262	287,326	$3,255,336
2019	1,080	216,632	$2,994,414
2020	1,019	195,358	$3,124,026
2021	1,135	266,371	$4,779,368
2022	965	230,163	$3,725,449
2023	914	204,555	$2,911,492
2024	983	201,651	$3,089,009

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	193	1,004	$974,039
2016	188	957	$1,024,945
2017	215	1,021	$957,442
2018	223	1,246	$1,717,752
2019	201	1,020	$1,572,694
2020	208	1,111	$2,676,014
2021	226	1,422	$3,948,514
2022	227	1,290	$4,243,814
2023	217	1,408	$3,976,704
2024	206	1,374	$4,579,879

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	49	$29,372
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	33	$10,541
2019	N/R	78	$9,328
2020	N/R	28	$2,720
2021	N/R	40	$3,573
2022	N/R	N/R	N/R
2023	N/R	47	$2,095
2024	N/R	86	$2,023

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	156	376	$92
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	229	628	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	203	263	$57
J0897	Injection, denosumab, 1 mg	160	13,020	$21
96372	Injection of drug or substance under skin or into muscle	251	500	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	61	1,708	$1,018,959
Imbruvica	Ibrutinib	37	1,068	$595,969
Revlimid	Lenalidomide	27	728	$539,200
Lenalidomide	Lenalidomide	29	812	$397,766
Cabometyx	Cabozantinib S-Malate	11	330	$254,473

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	40	$1,346
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	30	$376
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	16	$301

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for James W. Neel, MD?

Tedicare shows public-source Medicare data for James W. Neel, MD (NPI 1447232772), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James W. Neel, MD have ACO affiliation data?

James W. Neel, MD is shown with ACO affiliation data for Privia Quality Network Central Florida, LLC (MSSP, ACO ID A4947).

What billing organization is linked to James W. Neel, MD?

James W. Neel, MD is linked to HEALTH FIRST MEDICAL GROUP, LLC (billing NPI 1750626495) in the available physician profile data.

Does James W. Neel, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.